-
1 Comment
Jiangxi Synergy Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 10.5% below its 200 day moving average.
From a valuation standpoint, the stock is 14.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.2.
Jiangxi Synergy Pharmaceutical Co., Ltd's total revenue sank by 27.1% to $96M since the same quarter in the previous year.
Its net income has increased by 48.6% to $10M since the same quarter in the previous year.
Finally, its free cash flow fell by 48.3% to $-78M since the same quarter in the previous year.
Based on the above factors, Jiangxi Synergy Pharmaceutical Co., Ltd gets an overall score of 2/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100002P83 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 3B |
|---|---|
| PE Ratio | 36.3 |
| Target Price | 9.3 |
| Dividend Yield | 0.5% |
| Beta | 0.26 |
Jiangxi Synergy Pharmaceutical Co., Ltd. manufactures and sells APIs worldwide. It offers raw materials, pharmaceutical intermediates, and fine chemicals. Jiangxi Synergy Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Yichun, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300636.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
